BCTX (STOCKS)
Briacell Therapeutics Corp. Common Shares
$3.440000
+0.030000 (+0.88%)
Prev close: $3.410000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William V. Williams
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $30.41M
- Employees
- 4
- P/E (TTM)
- -0.28
- P/B (TTM)
- 1.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $475.41K |
| Operating Expenses | $32.03M |
| Research and Development | $25.81M |
| Other Operating Expenses | $6.21M |
| Operating Income/Loss | -$32.03M |
| Income/Loss Before Equity Method Investments | $22.35M |
| Income/Loss From Continuing Operations After Tax | $22.14M |
| Income/Loss From Continuing Operations Before Tax | $22.14M |
| Income/Loss From Equity Method Investments | -$218.50K |
| Net Income/Loss | -$30.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$301.12K |
| Net Income/Loss Attributable To Parent | -$30.68M |
| Net Income/Loss Available To Common Stockholders, Basic | -$30.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.03 |
| Diluted Earnings Per Share | -$0.84 |
| Basic Average Shares | 4,094,434 |
| Diluted Average Shares | 4,094,434 |
| Assets | $27.07M |
| Current Assets | $25.39M |
| Noncurrent Assets | $1.68M |
| Fixed Assets | $349.00K |
| Non-current Prepaid Expenses | $405.09K |
| Other Non-current Assets | $924.05K |
| Liabilities | $3.66M |
| Current Liabilities | $3.59M |
| Noncurrent Liabilities | $71.85K |
| Equity | $23.41M |
| Equity Attributable To Noncontrolling Interest | -$649.10K |
| Equity Attributable To Parent | $24.06M |
| Liabilities And Equity | $27.07M |
| Net Cash Flow From Operating Activities | -$30.82M |
| Net Cash Flow From Operating Activities, Continuing | -$30.82M |
| Net Cash Flow From Investing Activities | -$16.19M |
| Net Cash Flow From Investing Activities, Continuing | -$16.19M |
| Net Cash Flow From Financing Activities | $41.43M |
| Net Cash Flow From Financing Activities, Continuing | $41.43M |
| Net Cash Flow | -$5.58M |
| Net Cash Flow, Continuing | -$5.58M |
| Comprehensive Income/Loss | -$30.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$30.98M |
| Other Comprehensive Income/Loss | $0.00 |